Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 87 entries
Sorted by: Best Match Show Resources per page
Solitary Trichoepithelioma of the Eyelid: A Clinico-Pathological Correlation.

International journal of trichology

Gupta A, Ali MJ, Mishra DK, Naik MN.
PMID: 26180455
Int J Trichology. 2015 Apr-Jun;7(2):80-1. doi: 10.4103/0974-7753.160119.

Solitary trichoepithelioma of the eyelid is a very rare tumor, which needs to be differentiated from basaloid epithelioma and basal cell carcinoma. Diagnosis is based on clinical and histopathological examination. We present a case of an eyelid trichoepithelioma presenting...

Cite
Gupta A, Ali MJ, Mishra DK, et al. Solitary Trichoepithelioma of the Eyelid: A Clinico-Pathological Correlation. Int J Trichology. 2015;7(2):80-1doi: 10.4103/0974-7753.160119.
Gupta, A., Ali, M. J., Mishra, D. K., & Naik, M. N. (2015). Solitary Trichoepithelioma of the Eyelid: A Clinico-Pathological Correlation. International journal of trichology, 7(2), 80-1. https://doi.org/10.4103/0974-7753.160119
Gupta, Adit, et al. "Solitary Trichoepithelioma of the Eyelid: A Clinico-Pathological Correlation." International journal of trichology vol. 7,2 (2015): 80-1. doi: https://doi.org/10.4103/0974-7753.160119
Gupta A, Ali MJ, Mishra DK, Naik MN. Solitary Trichoepithelioma of the Eyelid: A Clinico-Pathological Correlation. Int J Trichology. 2015 Apr-Jun;7(2):80-1. doi: 10.4103/0974-7753.160119. PMID: 26180455; PMCID: PMC4502481.
Copy Download .nbib Format: NLM
Retinal astrocytic hamartoma and Bourneville's disease.

Oman journal of ophthalmology

Ali MJ, Honavar SG, Naik MN.
PMID: 23436975
Oman J Ophthalmol. 2012 Sep;5(3):198-9. doi: 10.4103/0974-620X.106108.

No abstract available.

Cite
Ali MJ, Honavar SG, Naik MN. Retinal astrocytic hamartoma and Bourneville's disease. Oman J Ophthalmol. 2012;5(3):198-9doi: 10.4103/0974-620X.106108.
Ali, M. J., Honavar, S. G., & Naik, M. N. (2012). Retinal astrocytic hamartoma and Bourneville's disease. Oman journal of ophthalmology, 5(3), 198-9. https://doi.org/10.4103/0974-620X.106108
Ali, Mohammad Javed, et al. "Retinal astrocytic hamartoma and Bourneville's disease." Oman journal of ophthalmology vol. 5,3 (2012): 198-9. doi: https://doi.org/10.4103/0974-620X.106108
Ali MJ, Honavar SG, Naik MN. Retinal astrocytic hamartoma and Bourneville's disease. Oman J Ophthalmol. 2012 Sep;5(3):198-9. doi: 10.4103/0974-620X.106108. PMID: 23436975; PMCID: PMC3574521.
Copy Download .nbib Format: NLM
Periorbital Biometric Measurements using ImageJ Software: Standardisation of Technique and Assessment Of Intra- and Interobserver Variability.

Journal of cutaneous and aesthetic surgery

Rajyalakshmi R, Prakash WD, Ali MJ, Naik MN.
PMID: 29403183
J Cutan Aesthet Surg. 2017 Jul-Sep;10(3):130-135. doi: 10.4103/JCAS.JCAS_61_17.

PURPOSE: To assess the reliability and repeatability of periorbital biometric measurements using ImageJ software and to assess if the horizontal visible iris diameter (HVID) serves as a reliable scale for facial measurements.METHODS: This study was a prospective, single-blind, comparative...

Cite
Rajyalakshmi R, Prakash WD, Ali MJ, et al. Periorbital Biometric Measurements using ImageJ Software: Standardisation of Technique and Assessment Of Intra- and Interobserver Variability. J Cutan Aesthet Surg. 2017;10(3):130-135doi: 10.4103/JCAS.JCAS_61_17.
Rajyalakshmi, R., Prakash, W. D., Ali, M. J., & Naik, M. N. (2017). Periorbital Biometric Measurements using ImageJ Software: Standardisation of Technique and Assessment Of Intra- and Interobserver Variability. Journal of cutaneous and aesthetic surgery, 10(3), 130-135. https://doi.org/10.4103/JCAS.JCAS_61_17
Rajyalakshmi, R, et al. "Periorbital Biometric Measurements using ImageJ Software: Standardisation of Technique and Assessment Of Intra- and Interobserver Variability." Journal of cutaneous and aesthetic surgery vol. 10,3 (2017): 130-135. doi: https://doi.org/10.4103/JCAS.JCAS_61_17
Rajyalakshmi R, Prakash WD, Ali MJ, Naik MN. Periorbital Biometric Measurements using ImageJ Software: Standardisation of Technique and Assessment Of Intra- and Interobserver Variability. J Cutan Aesthet Surg. 2017 Jul-Sep;10(3):130-135. doi: 10.4103/JCAS.JCAS_61_17. PMID: 29403183; PMCID: PMC5782436.
Copy Download .nbib Format: NLM
Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials.

Dermatology and therapy

Bertolotti A, Ferdynus C, Milpied B, Dupin N, Huiart L, Derancourt C.
PMID: 32030564
Dermatol Ther (Heidelb). 2020 Apr;10(2):249-262. doi: 10.1007/s13555-020-00357-z. Epub 2020 Feb 06.

INTRODUCTION: No hierarchy of first-line treatments for anogenital warts (AGWs) is provided in international guidelines. This study aimed to determine the efficacy of topical treatments and ablative procedures for the management of AGWs.METHODS: Twelve electronic databases were systematically searched...

Cite
Bertolotti A, Ferdynus C, Milpied B, et al. Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials. Dermatol Ther (Heidelb). 2020;10(2):249-262doi: 10.1007/s13555-020-00357-z.
Bertolotti, A., Ferdynus, C., Milpied, B., Dupin, N., Huiart, L., & Derancourt, C. (2020). Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials. Dermatology and therapy, 10(2), 249-262. https://doi.org/10.1007/s13555-020-00357-z
Bertolotti, Antoine, et al. "Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials." Dermatology and therapy vol. 10,2 (2020): 249-262. doi: https://doi.org/10.1007/s13555-020-00357-z
Bertolotti A, Ferdynus C, Milpied B, Dupin N, Huiart L, Derancourt C. Local Management of Anogenital Warts in Non-Immunocompromised Adults: A Network Meta-Analysis of Randomized Controlled Trials. Dermatol Ther (Heidelb). 2020 Apr;10(2):249-262. doi: 10.1007/s13555-020-00357-z. Epub 2020 Feb 06. PMID: 32030564; PMCID: PMC7090115.
Copy Download .nbib Format: NLM
Biochemical characterization, cloning and molecular modeling of a digestive lipase from red seabream (.

Engineering in life sciences

Smichi N, Fendri A, Triki S, Arondel V, Rebai A, Gargouri Y, Miled N.
PMID: 32624812
Eng Life Sci. 2017 Feb 06;17(6):664-677. doi: 10.1002/elsc.201600246. eCollection 2017 Jun.

Red seabream digestive lipase (RsDL) was purified from fresh pyloric caeca. Pure RsDL has an apparent molecular mass of 50 kDa. The RsDL is more active on short-chain triacylglycerols (TC

Cite
Smichi N, Fendri A, Triki S, et al. Biochemical characterization, cloning and molecular modeling of a digestive lipase from red seabream (. Eng Life Sci. 2017;17(6):664-677doi: 10.1002/elsc.201600246.
Smichi, N., Fendri, A., Triki, S., Arondel, V., Rebai, A., Gargouri, Y., & Miled, N. (2017). Biochemical characterization, cloning and molecular modeling of a digestive lipase from red seabream (. Engineering in life sciences, 17(6), 664-677. https://doi.org/10.1002/elsc.201600246
Smichi, Nabil, et al. "Biochemical characterization, cloning and molecular modeling of a digestive lipase from red seabream (." Engineering in life sciences vol. 17,6 (2017): 664-677. doi: https://doi.org/10.1002/elsc.201600246
Smichi N, Fendri A, Triki S, Arondel V, Rebai A, Gargouri Y, Miled N. Biochemical characterization, cloning and molecular modeling of a digestive lipase from red seabream (. Eng Life Sci. 2017 Feb 06;17(6):664-677. doi: 10.1002/elsc.201600246. eCollection 2017 Jun. PMID: 32624812; PMCID: PMC6999238.
Copy Download .nbib Format: NLM
Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!.

JAAD case reports

Luherne C, Darrigade AS, Dutriaux C, Prey S, Milpied B.
PMID: 31061867
JAAD Case Rep. 2019 Apr 28;5(5):422-423. doi: 10.1016/j.jdcr.2019.02.033. eCollection 2019 May.

No abstract available.

Cite
Luherne C, Darrigade AS, Dutriaux C, et al. Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!. JAAD Case Rep. 2019;5(5):422-423doi: 10.1016/j.jdcr.2019.02.033.
Luherne, C., Darrigade, A. S., Dutriaux, C., Prey, S., & Milpied, B. (2019). Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!. JAAD case reports, 5(5), 422-423. https://doi.org/10.1016/j.jdcr.2019.02.033
Luherne, Camille, et al. "Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!." JAAD case reports vol. 5,5 (2019): 422-423. doi: https://doi.org/10.1016/j.jdcr.2019.02.033
Luherne C, Darrigade AS, Dutriaux C, Prey S, Milpied B. Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!. JAAD Case Rep. 2019 Apr 28;5(5):422-423. doi: 10.1016/j.jdcr.2019.02.033. eCollection 2019 May. PMID: 31061867; PMCID: PMC6488678.
Copy Download .nbib Format: NLM
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.

American journal of hematology

Nagler A, Labopin M, Craddock C, Socié G, Yakoub-Agha I, Gedde-Dahl T, Niittyvuopio R, Byrne JL, Cornelissen JJ, Labussière-Wallet H, Arcese W, Milpied N, Esteve J, Canaani J, Mohty M.
PMID: 34978724
Am J Hematol. 2022 Jan 03; doi: 10.1002/ajh.26442. Epub 2022 Jan 03.

FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) mutational status is a pivotal prognosticator in acute myeloid leukemia (AML) patients and significantly increases the risk of disease relapse. However, it remains unclear whether in FLT3-ITD patients referred for allogeneic...

Cite
Nagler A, Labopin M, Craddock C, et al. Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation. Am J Hematol. 2022;doi: 10.1002/ajh.26442.
Nagler, A., Labopin, M., Craddock, C., Socié, G., Yakoub-Agha, I., Gedde-Dahl, T., Niittyvuopio, R., Byrne, J. L., Cornelissen, J. J., Labussière-Wallet, H., Arcese, W., Milpied, N., Esteve, J., Canaani, J., & Mohty, M. (2022). Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation. American journal of hematology, . https://doi.org/10.1002/ajh.26442
Nagler, Arnon, et al. "Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation." American journal of hematology vol. (2022). doi: https://doi.org/10.1002/ajh.26442
Nagler A, Labopin M, Craddock C, Socié G, Yakoub-Agha I, Gedde-Dahl T, Niittyvuopio R, Byrne JL, Cornelissen JJ, Labussière-Wallet H, Arcese W, Milpied N, Esteve J, Canaani J, Mohty M. Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation. Am J Hematol. 2022 Jan 03; doi: 10.1002/ajh.26442. Epub 2022 Jan 03. PMID: 34978724.
Copy Download .nbib Format: NLM
Lower eyelid entropion in thyroid eye disease.

Orbit (Amsterdam, Netherlands)

Vasanthapuram VH, Naik MN.
PMID: 33775197
Orbit. 2021 Mar 29;1-6. doi: 10.1080/01676830.2021.1905669. Epub 2021 Mar 29.

No abstract available.

Cite
Vasanthapuram VH, Naik MN. Lower eyelid entropion in thyroid eye disease. Orbit. 2021;1-6doi: 10.1080/01676830.2021.1905669.
Vasanthapuram, V. H., & Naik, M. N. (2021). Lower eyelid entropion in thyroid eye disease. Orbit (Amsterdam, Netherlands), 1-6. https://doi.org/10.1080/01676830.2021.1905669
Vasanthapuram, Varshitha Hemanth, and Naik, Milind N. "Lower eyelid entropion in thyroid eye disease." Orbit (Amsterdam, Netherlands) vol. (2021): 1-6. doi: https://doi.org/10.1080/01676830.2021.1905669
Vasanthapuram VH, Naik MN. Lower eyelid entropion in thyroid eye disease. Orbit. 2021 Mar 29;1-6. doi: 10.1080/01676830.2021.1905669. Epub 2021 Mar 29. PMID: 33775197.
Copy Download .nbib Format: NLM
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia.

Cellular & molecular immunology

Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É.
PMID: 34588630
Cell Mol Immunol. 2021 Nov;18(11):2578-2580. doi: 10.1038/s41423-021-00771-z.

No abstract available.

Cite
Crinier A, Dumas PY, Escalière B, et al. Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cell Mol Immunol. 2021;18(11):2578-2580doi: 10.1038/s41423-021-00771-z.
Crinier, A., Dumas, P. Y., Escalière, B., Piperoglou, C., Gil, L., Villacreces, A., Vély, F., Ivanovic, Z., Milpied, P., Narni-Mancinelli, �. �., & Vivier, �. �. (2021). Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cellular & molecular immunology, 18(11), 2578-2580. https://doi.org/10.1038/s41423-021-00771-z
Crinier, Adeline, et al. "Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia." Cellular & molecular immunology vol. 18,11 (2021): 2578-2580. doi: https://doi.org/10.1038/s41423-021-00771-z
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cell Mol Immunol. 2021 Nov;18(11):2578-2580. doi: 10.1038/s41423-021-00771-z. PMID: 34588630; PMCID: PMC8546152.
Copy Download .nbib Format: NLM
Cleaner degreasing of sheepskins by the Yarrowia lipolytica LIP2 lipase as a chemical-free alternative in the leather industry.

Colloids and surfaces. B, Biointerfaces

Moujehed E, Zarai Z, Khemir H, Miled N, Bchir MS, Gablin C, Bessueille F, Bonhommé A, Leonard D, Carrière F, Aloulou A.
PMID: 34954514
Colloids Surf B Biointerfaces. 2021 Dec 17;211:112292. doi: 10.1016/j.colsurfb.2021.112292. Epub 2021 Dec 17.

Conventional degreasing of skins and hides in the leather industry requires high amounts of organic solvents and detergents that cause environmental issues. In this study, the LIP2 lipase from the yeast Yarrowia lipolytica (YLLIP2) was shown to be effective...

Cite
Moujehed E, Zarai Z, Khemir H, et al. Cleaner degreasing of sheepskins by the Yarrowia lipolytica LIP2 lipase as a chemical-free alternative in the leather industry. Colloids Surf B Biointerfaces. 2021;211:112292doi: 10.1016/j.colsurfb.2021.112292.
Moujehed, E., Zarai, Z., Khemir, H., Miled, N., Bchir, M. S., Gablin, C., Bessueille, F., Bonhommé, A., Leonard, D., Carrière, F., & Aloulou, A. (2021). Cleaner degreasing of sheepskins by the Yarrowia lipolytica LIP2 lipase as a chemical-free alternative in the leather industry. Colloids and surfaces. B, Biointerfaces, 211112292. https://doi.org/10.1016/j.colsurfb.2021.112292
Moujehed, Emna, et al. "Cleaner degreasing of sheepskins by the Yarrowia lipolytica LIP2 lipase as a chemical-free alternative in the leather industry." Colloids and surfaces. B, Biointerfaces vol. 211 (2021): 112292. doi: https://doi.org/10.1016/j.colsurfb.2021.112292
Moujehed E, Zarai Z, Khemir H, Miled N, Bchir MS, Gablin C, Bessueille F, Bonhommé A, Leonard D, Carrière F, Aloulou A. Cleaner degreasing of sheepskins by the Yarrowia lipolytica LIP2 lipase as a chemical-free alternative in the leather industry. Colloids Surf B Biointerfaces. 2021 Dec 17;211:112292. doi: 10.1016/j.colsurfb.2021.112292. Epub 2021 Dec 17. PMID: 34954514.
Copy Download .nbib Format: NLM
Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent.

Indian journal of ophthalmology

Pradhan A, Ganguly A, Naik MN, Nair AG, Desai S, Rath S.
PMID: 32709788
Indian J Ophthalmol. 2020 Aug;68(8):1609-1614. doi: 10.4103/ijo.IJO_1918_19.

PURPOSE: To evaluate the current practice patterns in the treatment of thyroid eye disease (TED) in Indian subcontinent through a web-based survey of members of Oculoplastics Association of India (OPAI).METHODS: This was an online web-based questionnaire survey disseminated via...

Cite
Pradhan A, Ganguly A, Naik MN, et al. Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent. Indian J Ophthalmol. 2020;68(8):1609-1614doi: 10.4103/ijo.IJO_1918_19.
Pradhan, A., Ganguly, A., Naik, M. N., Nair, A. G., Desai, S., & Rath, S. (2020). Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent. Indian journal of ophthalmology, 68(8), 1609-1614. https://doi.org/10.4103/ijo.IJO_1918_19
Pradhan, Anuradha, et al. "Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent." Indian journal of ophthalmology vol. 68,8 (2020): 1609-1614. doi: https://doi.org/10.4103/ijo.IJO_1918_19
Pradhan A, Ganguly A, Naik MN, Nair AG, Desai S, Rath S. Thyroid eye disease survey: An anonymous web-based survey in the Indian subcontinent. Indian J Ophthalmol. 2020 Aug;68(8):1609-1614. doi: 10.4103/ijo.IJO_1918_19. PMID: 32709788; PMCID: PMC7640870.
Copy Download .nbib Format: NLM
Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.

Bone marrow transplantation

Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC, Lanza F, Shouval R, Versluis J, Bug G, Fløisand Y, Ciceri F, Sanz J, Bazarbachi A, Nagler A, Mohty M.
PMID: 32144364
Bone Marrow Transplant. 2020 Jun;55(6):1213. doi: 10.1038/s41409-020-0835-3.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Spyridonidis A, Labopin M, Savani BN, et al. Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone Marrow Transplant. 2020;55(6):1213doi: 10.1038/s41409-020-0835-3.
Spyridonidis, A., Labopin, M., Savani, B. N., Niittyvuopio, R., Blaise, D., Craddock, C., Socié, G., Platzbecker, U., Beelen, D., Milpied, N., Cornelissen, J. J., Ganser, A., Huynh, A., Griskevicius, L., Giebel, S., Aljurf, M., Brissot, E., Malard, F., Esteve, J., Peric, Z., Baron, F., Ruggeri, A., Schmid, C., Gilleece, M., Gorin, N. C., Lanza, F., Shouval, R., Versluis, J., Bug, G., Fløisand, Y., Ciceri, F., Sanz, J., Bazarbachi, A., Nagler, A., & Mohty, M. (2020). Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone marrow transplantation, 55(6), 1213. https://doi.org/10.1038/s41409-020-0835-3
Spyridonidis, Alexandros, et al. "Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients." Bone marrow transplantation vol. 55,6 (2020): 1213. doi: https://doi.org/10.1038/s41409-020-0835-3
Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, Socié G, Platzbecker U, Beelen D, Milpied N, Cornelissen JJ, Ganser A, Huynh A, Griskevicius L, Giebel S, Aljurf M, Brissot E, Malard F, Esteve J, Peric Z, Baron F, Ruggeri A, Schmid C, Gilleece M, Gorin NC, Lanza F, Shouval R, Versluis J, Bug G, Fløisand Y, Ciceri F, Sanz J, Bazarbachi A, Nagler A, Mohty M. Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone Marrow Transplant. 2020 Jun;55(6):1213. doi: 10.1038/s41409-020-0835-3. PMID: 32144364.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 87 entries